201 related articles for article (PubMed ID: 36671477)
1. Ploidy Status of Ovarian Cancer Cell Lines and Their Association with Gene Expression Profiles.
Du M; Zhang S; Liu X; Xu C; Zhang X
Biomolecules; 2023 Jan; 13(1):. PubMed ID: 36671477
[TBL] [Abstract][Full Text] [Related]
2. Aneuploid serves as a prognostic marker and favors immunosuppressive microenvironment in ovarian cancer.
Du M; Cai Q; Sun J; Zhang M; Zhang S; Liu X; Zhang M; Zhang X
J Ovarian Res; 2024 Feb; 17(1):30. PubMed ID: 38308314
[TBL] [Abstract][Full Text] [Related]
3. [DNA ploidy and results of first line chemotherapy in ovarian cancer patients].
Milczek T; Klasa-Mazurkiewicz D; Emerich J; Debniak J
Ginekol Pol; 2006 Aug; 77(8):589-96. PubMed ID: 17076189
[TBL] [Abstract][Full Text] [Related]
4. Relationship between chromosomal instability and intratumoral regional DNA ploidy heterogeneity in primary gastric cancers.
Furuya T; Uchiyama T; Murakami T; Adachi A; Kawauchi S; Oga A; Hirano T; Sasaki K
Clin Cancer Res; 2000 Jul; 6(7):2815-20. PubMed ID: 10914729
[TBL] [Abstract][Full Text] [Related]
5. Flow cytometric analysis of nuclear DNA content in ovarian tumors. Association of ploidy with tumor type, histologic grade, and clinical stage.
Lage JM; Weinberg DS; Huettner PC; Mark SD
Cancer; 1992 Jun; 69(11):2668-75. PubMed ID: 1571896
[TBL] [Abstract][Full Text] [Related]
6. Novel near-diploid ovarian cancer cell line derived from a highly aneuploid metastatic ovarian tumor.
Rozenblum E; Sotelo-Silveira JR; Kim GY; Zhu JY; Lau CC; McNeil N; Korolevich S; Liao H; Cherry JM; Munroe DJ; Ried T; Meltzer PS; Kuehl WM; Roschke AV
PLoS One; 2017; 12(8):e0182610. PubMed ID: 28787462
[TBL] [Abstract][Full Text] [Related]
7. Ploidy analysis of epithelial ovarian cancers using image cytometry.
Berchuck A; Boente MP; Kerns BJ; Kinney RB; Soper JT; Clarke-Pearson DL; Bast RC; Bacus SS
Gynecol Oncol; 1992 Jan; 44(1):61-5. PubMed ID: 1370427
[TBL] [Abstract][Full Text] [Related]
8. Ploidy assessment of benign and malignant ovarian tumors by flow cytometry. A clinicopathologic study.
Iversen OE; Skaarland E
Cancer; 1987 Jul; 60(1):82-7. PubMed ID: 3581034
[TBL] [Abstract][Full Text] [Related]
9. Tumor DNA ploidy and prognosis of patients with serous cystadenocarcinoma of the ovary.
Kigawa J; Minagawa Y; Ishihara H; Kanamori Y; Terakawa N
Cancer; 1993 Aug; 72(3):804-8. PubMed ID: 8334634
[TBL] [Abstract][Full Text] [Related]
10. Large-scale genomic instability predicts long-term outcome for women with invasive stage I ovarian cancer.
Kristensen GB; Kildal W; Abeler VM; Kaern J; Vergote I; Tropé CG; Danielsen HE
Ann Oncol; 2003 Oct; 14(10):1494-500. PubMed ID: 14504048
[TBL] [Abstract][Full Text] [Related]
11. Tumour ploidy, morphometry, histological grading and clinical features in ovarian carcinoma: mutual relations.
Haapasalo H; Atkin NB; Collan Y; Pesonen E; Paljärvi L
Anal Cell Pathol; 1991 Sep; 3(5):261-71. PubMed ID: 1931753
[TBL] [Abstract][Full Text] [Related]
12. Flow cytometric DNA ploidy and S-phase heterogeneity in advanced ovarian carcinoma.
Kaern J; Tropé CG; Kristensen GB; Pettersen EO
Cancer; 1994 Apr; 73(7):1870-7. PubMed ID: 8137213
[TBL] [Abstract][Full Text] [Related]
13. DNA ploidy analysis of pediatric germ cell tumors.
Silver SA; Wiley JM; Perlman EJ
Mod Pathol; 1994 Dec; 7(9):951-6. PubMed ID: 7892165
[TBL] [Abstract][Full Text] [Related]
14. Tetraploid cells from cytokinesis failure induce aneuploidy and spontaneous transformation of mouse ovarian surface epithelial cells.
Lv L; Zhang T; Yi Q; Huang Y; Wang Z; Hou H; Zhang H; Zheng W; Hao Q; Guo Z; Cooke HJ; Shi Q
Cell Cycle; 2012 Aug; 11(15):2864-75. PubMed ID: 22801546
[TBL] [Abstract][Full Text] [Related]
15. DNA ploidy is stronger than lymph node metastasis as prognostic factor in cervical carcinoma: 10-year results of a prospective study.
Susini T; Olivieri S; Molino C; Amunni G; Rapi S; Taddei G; Scarselli G
Int J Gynecol Cancer; 2011 May; 21(4):678-84. PubMed ID: 21412157
[TBL] [Abstract][Full Text] [Related]
16. Multivariate analysis of the prognostic significance of DNA-ploidy and S-phase fraction in ovarian cancer determined by flow cytometry following detection of cytokeratin-labeled tumor cells.
Kimmig R; Wimberger P; Hillemanns P; Kapsner T; Caspari C; Hepp H
Gynecol Oncol; 2002 Jan; 84(1):21-31. PubMed ID: 11748971
[TBL] [Abstract][Full Text] [Related]
17. PRKDC-Mediated NHEJ May Play a Crucial Role in Aneuploidy of Chromosome 8-Driven Progression of Ovarian Cancer.
Luan W; Cheng H; Xie H; Liu H; Wang Y; Wang S; Ye X; Zhu H; Tang F; Li Y; Chang X
Int J Mol Sci; 2024 Apr; 25(9):. PubMed ID: 38732044
[TBL] [Abstract][Full Text] [Related]
18. Prognostic significance of tumor ploidy in patients with advanced ovarian carcinoma.
Khoo SK; Hurst T; Kearsley J; Dickie G; Free K; Parsons PG; Whitaker S; Ward B
Gynecol Oncol; 1990 Dec; 39(3):284-8. PubMed ID: 2258072
[TBL] [Abstract][Full Text] [Related]
19. DNA-ploidy in advanced gastric carcinoma is less heterogeneous than in early gastric cancer.
Osterheld MC; Caron L; Demierre M; Laurini R; Bosman FT
Cell Oncol; 2004; 26(1-2):21-9. PubMed ID: 15371654
[TBL] [Abstract][Full Text] [Related]
20. Analysis of genetic alterations associated with DNA diploidy, aneuploidy and multiploidy in gastric cancers.
Sugai T; Habano W; Jiao YF; Suzuki M; Takagane A; Nakamura S
Oncology; 2005; 68(4-6):548-57. PubMed ID: 16037688
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
